Regulus Therapeutics Inc (NASDAQ:RGLS)

0.72
Delayed Data
As of 4:00pm ET
 +0.0198 / +2.83%
Today’s Change
0.63
Today|||52-Week Range
1.60
-30.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues18.0K18.0K18.0K18.0K
 
 
 
 
 
Depreciation And Amortization658.0K585.0K582.0K563.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.7M14.8M13.1M15.0M
 
 
 
 
 
Research And Development14.3M12.7M10.5M11.6M
 
 
 
 
 
Total Operating Expenses21.3M15.4M13.7M15.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.3M-15.4M-13.7M-15.6M
 
 
 
 
 
Interest Expense On Debt603.0K580.0K993.0K605.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.7M-15.8M-14.5M-16.0M
 
 
 
 
 
Income Taxes-128.0K-7.0K-58.0K-1.0K
 
 
 
 
 
Net Income-21.6M-15.8M-14.4M-16.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS53.2M90.1M104.0M104.0M
 
 
 
 
 
Shares To Calculate EPS Diluted53.2M90.1M104.0M104.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.41-$0.18-$0.14-$0.15
 
 
 
 
 
EPS Diluted-$0.41-$0.18-$0.14-$0.15